Clarus Lifesciences III, L.P.'s Net Worth

$230 Million

Who is Clarus Lifesciences III, L.P.?

Clarus Lifesciences III, L.P. has an estimated net worth of $230 Million. This is based on reported shares across multiple companies, which include Imago BioSciences, Inc., Talaris Therapeutics, Inc., Praxis Precision Medicines, Inc., ESSA Pharma Inc., GRAYBUG VISION, INC., Annexon, Inc., Gritstone Oncology, Inc., Entasis Therapeutics Holdings Inc., AVROBIO, Inc., and Forty Seven, Inc..

SEC CIK

Clarus Lifesciences III, L.P.'s CIK is 0001597143

Past Insider Trading and Trends

2021 was Clarus Lifesciences III, L.P.'s most active year for acquiring shares with 24 total transactions. Clarus Lifesciences III, L.P.'s most active month to acquire stocks was the month of April. 2021 was Clarus Lifesciences III, L.P.'s most active year for disposing of shares, totalling 17 transactions. Clarus Lifesciences III, L.P.'s most active month to dispose stocks was the month of April. 2018 saw Clarus Lifesciences III, L.P. paying a total of $15,000,920.00 for 10,897,869 shares, this is the most they've acquired in one year. In 2021 Clarus Lifesciences III, L.P. cashed out on 49,042,428 shares for a total of $0.00, their largest year based on trade value.